Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients - Wikidata - wikimedia - TriplyDB

Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients

Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients

http://www.wikidata.org/entity/Q35095543

about

Osteooncology - Specific Aspects in Breast Cancer Patients.

P2860

Q35095533-1F3F75BE-B009-4268-A26A-C1FB38596FE5

P2860

Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients

http://www.wikidata.org/entity/Q35095543

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients

@ast

Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients

@en

type

label

Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients

@ast

Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients

@en

prefLabel

Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients

@ast

Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients

@en

P1433

Q35095543-D1BBEFF9-7187-4389-9D16-F9EDC5143711

P1476

Q35095543-EF841F0C-04C9-4A85-867F-C7FE4BBC04EA

P2093

Q35095543-8B1DCC69-2DBE-41F4-8F40-C34BBAE9C3EC

P2860

Q35095543-0E6EA233-8A30-459F-B1AC-30CD4F28DD45

Q35095543-12F35DF6-9DED-4AF6-AB06-6435E6B3307B

Q35095543-1898A37C-FF73-4A24-99F6-914C0FE04A40

Q35095543-20289462-80C6-4D68-8B3C-7B5B2BE17666

Q35095543-25489249-FBA3-4E47-8AE0-66EA6C6849FD

Q35095543-3BE4DEB7-B358-44EF-AB3C-326D0F2B96CE

Q35095543-42ADC6A8-4648-41C8-907A-41DA70378D6A

Q35095543-482CD9A6-CB9C-4391-B9F2-6F20A15555AD

Q35095543-4F40F6B2-2D27-4189-B594-6E2CE3C7B76D

Q35095543-5DCDE6C1-CD07-4C65-AF3C-00086D2D6735

P304

Q35095543-D4BC931C-4F15-4253-80D5-AE0758A85A6C

P31

Q35095543-8C6F14A9-9BC6-424A-98AE-1AB913147AD5

P356

Q35095543-D328A496-D762-443B-852E-45BDA27C36F0

P433

Q35095543-0646486E-ECED-4C18-A17B-6247E809BC72

P478

Q35095543-70822786-A067-401E-A2A4-91B29937C008

P577

Q35095543-C1F25473-73D6-41BB-B60A-4DCCE89E39D1

P5875

Q35095543-A149E172-92BE-484A-938F-9C718344B1C5

P698

Q35095543-58840482-DC4A-41E4-B961-A875B25F86B0

P932

Q35095543-60DEF3FC-8392-4B3A-968F-B1E4B9C8D4BF

P356

P1433

P1476

Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients

@en

P2093

Michael Gnant

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Metastasis to bone: causes, consequences and therapeutic opportunities

Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial.

Osteoporosis due to cancer treatment: pathogenesis and management.

Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.

Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer.

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

P304

298-304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000322099

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51511645

http://www.w3.org/2001/XMLSchema#string

P698

21779211

http://www.w3.org/2001/XMLSchema#string

P932

3132953

http://www.w3.org/2001/XMLSchema#string